Franklin Covey Co. (FC)
| Market Cap | 231.58M -19.9% |
| Revenue (ttm) | 262.75M -6.1% |
| Net Income | 2.19M -79.5% |
| EPS | 0.18 -77.4% |
| Shares Out | 11.29M |
| PE Ratio | 111.42 |
| Forward PE | 19.16 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 37,909 |
| Open | 21.45 |
| Previous Close | 21.69 |
| Day's Range | 20.45 - 21.71 |
| 52-Week Range | 11.16 - 26.81 |
| Beta | 0.80 |
| Analysts | Strong Buy |
| Price Target | 31.00 (+51.18%) |
| Earnings Date | Jul 1, 2026 |
About FC
Franklin Covey Co. provides training and consulting services in the areas of leadership, customer loyalty, execution, productivity, sales performance, and educational improvement for organizations and individuals worldwide. The company operates through four segments: North America, International Direct Offices, International Licensees, and Education Division. It offers a suite of individual-effectiveness and leadership-development training and products, such as The 7 Habits of Highly Effective People, The Speed of Trust, The Leader In Me, The F... [Read more]
Financial Performance
In fiscal year 2025, Franklin Covey Co.'s revenue was $267.07 million, a decrease of -7.02% compared to the previous year's $287.23 million. Earnings were $3.07 million, a decrease of -86.89%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for FC stock is "Strong Buy." The 12-month stock price target is $31.0, which is an increase of 51.18% from the latest price.
News
Franklin Covey price target raised to $25 from $22 at Roth Capital
Roth Capital analyst Jeff Martin raised the firm’s price target on Franklin Covey (FC) to $25 from $22 and keeps a Buy rating on the shares. Franklin Covey is expected…
Franklin Covey Co. Earnings Call Transcript: Q3 2026
Third quarter revenue grew 1% year-over-year to $67.8 million, with strong performance in Enterprise North America and Education. Adjusted EBITDA rose 14%, and deferred revenue increased 7% to $96 million, supporting a positive outlook for fiscal 2027.
Franklin Covey Co. Earnings release: Q3 2026
Franklin Covey Co. released its Q3 2026 earnings on July 1, 2026, summarizing the period's financial results.
Franklin Covey Co. Slides: Q3 2026
Franklin Covey Co. has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on July 1, 2026.
Franklin Covey Co. Quarterly report: Q3 2026
Franklin Covey Co. has published its Q3 2026 quarterly earnings report on July 1, 2026.
Franklin Covey Reports Third Quarter Fiscal 2026 Financial Results
SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner that gives strategy the human edge, announced today its financial results for...
The AI Winners Won't Just Be The Most Technological. They'll Be The Most Human.
SALT LAKE CITY--(BUSINESS WIRE)-- #AI--The AI Winners Won't Just Be The Most Technological. They'll Be The Most Human.
Franklin Covey to Report Third Quarter Fiscal 2026 Results
SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner that gives strategy the human edge, announced today that the conference call ...
Firm Capital Mortgage Investment Corporation Announces Election of Directors
/NOT FOR DISTRIBUTION OVER U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Firm Capital Mortgage Investment Corporation (the “Corporation”) (T...
FranklinCovey Will Host James Patterson, Liz Wiseman, Patrick Leddin and Jennifer Colosimo to Help HR and L&D Leaders Close Critical Leadership Gaps and Lead Through Disruption
SALT LAKE CITY--(BUSINESS WIRE)-- #Change--FranklinCovey will Host James Patterson, Liz Wiseman, Patrick Leddin and Jennifer Colosimo on Two Webinars for HR and L&D Leaders on June 26 and 30.
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living with gastrointestinal (GI) and ...
80% of Individual Contributors Say Their Manager's Approach to AI is Hands-Off, FranklinCovey Research Finds
SALT LAKE CITY--(BUSINESS WIRE)-- #AI--As organizations race to capture the benefits of artificial intelligence, research from FranklinCovey Institute reveals a critical obstacle: most employees feel ...
Firm Capital Mortgage Investment Corporation Announces Q1/2026 Results and Declares Monthly Cash Dividends for July, August and September 2026
TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB. K, FC.DB. L and FC.DB.M) today released its financial statements for the thre...
Franklin Covey Co. Earnings Call Transcript: Q2 2026
Q2 saw year-over-year growth in revenue and Adjusted EBITDA, with strong invoiced amounts and deferred revenue positioning the company for accelerated growth in fiscal 2027. Education and international segments performed well, and guidance for fiscal 2026 was reaffirmed.
Franklin Covey Co. Quarterly report: Q2 2026
Franklin Covey Co. has published its Q2 2026 quarterly earnings report on April 1, 2026.
Franklin Covey Co. Earnings release: Q2 2026
Franklin Covey Co. released its Q2 2026 earnings on April 1, 2026, summarizing the period's financial results.
Franklin Covey Co. Slides: Q2 2026
Franklin Covey Co. has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on April 1, 2026.
Franklin Covey Reports Second Quarter Fiscal 2026 Financial Results
SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner, gives strategy the human edge. We help clients achieve breakthrough results ...
FranklinCovey Provides Customized Solutions for Healthcare Organizations to Solve Key Issues: Nurse Retention and Patient Satisfaction
SALT LAKE CITY--(BUSINESS WIRE)-- #CNO--FranklinCovey Provides Customized Solutions for Healthcare Organizations to Solve Key Issues: Nurse Retention and Patient Satisfaction.
Franklin Covey to Report Second Quarter Fiscal 2026 Results
DRAPER, Utah--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement, announced today that the conference call to review the Company's second quarter 2026 f...
FranklinCovey's New Insight Report, Where Are All The Great Leaders?, Reveals Need for Exceptional Leaders in 2026 as Disruption, Eroding Trust, and AI Continue to Redefine Leadership
SALT LAKE CITY--(BUSINESS WIRE)-- #AIAdoption--FranklinCovey's Insight Report, Where Are All the Great Leaders? Reveals Need for Exceptional Leaders In 2026 Due to Disruption, Eroding Trust and AI.
Training Industry Selects FranklinCovey as a 2026 Top 20 Sales Training Company, Yet Again
SALT LAKE CITY--(BUSINESS WIRE)-- #2026Top20SalesTrainingCompany--Training Industry Selects FranklinCovey as a 2026 Top 20 Sales Training Company, Yet Again: Its Helping Clients Succeed Solution, Rece...
Franklin Covey price target raised to $25 from $22 at Barrington
Barrington raised the firm’s price target on Franklin Covey (FC) to $25 from $22 and keeps an Outperform rating on the shares. The firm expects the company to see accelerated…
Franklin Covey Co. Earnings Call Transcript: Q1 2026
Q1 saw a return to growth in invoiced amounts, especially in Enterprise North America, with strong new logo wins and increased multi-year contracts. Revenue and EBITDA guidance for fiscal 2026 are reaffirmed, with growth expected to accelerate in 2027.
Franklin Covey Co. Quarterly report: Q1 2026
Franklin Covey Co. has published its Q1 2026 quarterly earnings report on January 7, 2026.